Keywords: Britsol-Myers Squibb, Second-quarter 2011 financial results
Bristol-Myers Squibb raises forecast as strong 2nd-qtr 2011 results beat forecasts
Article | 29 July 2011
US drug major Bristol-Myers Squibb (NYSE: BMY) yesterday reported second-quarter 2011 net profit of $902 million, or $0.52 a share, down nearly 3% due ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
